MAP-04-03

General Information


DRACP ID  DRACP02398

Peptide Name   MAP-04-03

Sequence  KWLRRVWRWWR

Sequence Length  11

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane lysis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=61.5 μM MTT assay 48 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02398

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C85H122N28O12

Absent amino acids  ACDEFGHIMNPQSTY

Common amino acids  RW

Mass  190662

Pl  12.98

Basic residues  5

Acidic residues  0

Hydrophobic residues  6

Net charge  5

Boman Index  -4695

Hydrophobicity  -159.09

Aliphatic Index  61.82

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  22000

Absorbance 280nm  2200

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23993331

Title  Anticancer activities of an antimicrobial peptide derivative of Ixosin-B amide

Doi 10.1016/j.bmcl.2013.07.063

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_4584

DRACP is developed by Dr.Zheng's team.